Does LAROTRECTINIB Cause Disease progression? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Disease progression have been filed in association with LAROTRECTINIB (VITRAKVI). This represents 3.4% of all adverse event reports for LAROTRECTINIB.
27
Reports of Disease progression with LAROTRECTINIB
3.4%
of all LAROTRECTINIB reports
3
Deaths
1
Hospitalizations
How Dangerous Is Disease progression From LAROTRECTINIB?
Of the 27 reports, 3 (11.1%) resulted in death, 1 (3.7%) required hospitalization.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for LAROTRECTINIB.
What Other Side Effects Does LAROTRECTINIB Cause?
Fatigue (56)
Drug ineffective (52)
Dizziness (50)
Death (48)
Pain (42)
Neuropathy peripheral (39)
Nausea (32)
Off label use (31)
Malignant neoplasm progression (23)
Myalgia (23)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which LAROTRECTINIB Alternatives Have Lower Disease progression Risk?
LAROTRECTINIB vs LASILIX
LAROTRECTINIB vs LASIX
LAROTRECTINIB vs LASMIDITAN
LAROTRECTINIB vs LATANOPROST
LAROTRECTINIB vs LATANOPROSTENE BUNOD